Patent details

EP4176048 Title: GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUPTION HAVE IMPROVED FUNCTIONALITY AND PERSISTENCE

Basic Information

Publication number:
EP4176048
PCT Application Number:
IB2021058704
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP217870427
PCT Publication Number:
WO2022064428
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUPTION HAVE IMPROVED FUNCTIONALITY AND PERSISTENCE
French Title of Invention:
LYMPHOCYTES T GÉNÉTIQUEMENT MODIFIÉS À INTERRUPTION DE REGNASE-1 ET/OU DE TGFBRII AYANT UNE FONCTIONNALITÉ ET UNE PERSISTANCE AMÉLIORÉES
German Title of Invention:
GENETISCH VERÄNDERTE T-ZELLEN MIT REGNASE-1 UND/ODER TGFBRII-UNTERBRECHUNG MIT VERBESSERTER FUNKTIONALITÄT UND PERSISTENZ
SPC Number:

Dates

Filing date:
23/09/2021
Grant date:
11/09/2024
EP Publication Date:
10/05/2023
PCT Publication Date:
31/03/2022
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/09/2024
EP B1 Publication Date:
11/09/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
23/09/2024
Expiration date:
23/09/2041
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/09/2024
 
 

Name:
CRISPR Therapeutics AG
Address:
Baarerstrasse 14, 6300 Zug, Switzerland (CH)

Inventor

1

Name:
KALAITZIDIS, Demetrios
Address:
United States (US)

2

Name:
GHONIME, Mohammed
Address:
United States (US)

3

Name:
DEQUEANT, Mary-Lee
Address:
United States (US)

Priority

1

Priority Number:
202063082357 P
Priority Date:
23/09/2020
Priority Country:
United States (US)

2

Priority Number:
202063124429 P
Priority Date:
11/12/2020
Priority Country:
United States (US)

3

Priority Number:
202163225673 P
Priority Date:
26/07/2021
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/00; C12N 5/0783; A61K 35/17; A61K 38/00; C12N 15/113; C12N 15/90; A61K 48/00;

Publication

European Patent Bulletin

Issue number:
202437
Publication date:
11/09/2024
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages